Search details
1.
Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases.
Clin Gastroenterol Hepatol
; 22(1): 135-143.e8, 2024 01.
Article
in English
| MEDLINE | ID: mdl-37442315
2.
Dynamic Prediction of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 2024 Feb 29.
Article
in English
| MEDLINE | ID: mdl-38431223
3.
Long-term outcome of risankizumab in Crohn's disease: a real-world GETAID study.
Clin Gastroenterol Hepatol
; 2024 May 08.
Article
in English
| MEDLINE | ID: mdl-38729389
4.
Endoscopic Gastrointestinal Placement of Capsule Endoscopy to Investigate the Small Bowel: a Multicentric European Retrospective Series of 630 Procedures in Adult Patients.
Gastrointest Endosc
; 2024 Jan 23.
Article
in English
| MEDLINE | ID: mdl-38272273
5.
Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases.
Gut
; 72(7): 1296-1307, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36270778
6.
Risk of Recurrent Acute Arterial Events Associated With Thiopurines and Anti-Tumor Necrosis Factor in Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 21(1): 164-172.e11, 2023 01.
Article
in English
| MEDLINE | ID: mdl-35842123
7.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 21(3): 771-788.e10, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36152897
8.
Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn's disease.
Gut
; 71(9): 1781-1789, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35387877
9.
Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 20(2): 314-324.e16, 2022 02.
Article
in English
| MEDLINE | ID: mdl-33387667
10.
Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: Epidemiology.
Br J Dermatol
; 187(5): 692-703, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35718888
11.
Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy.
Pharmacoepidemiol Drug Saf
; 31(2): 167-175, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34498314
12.
Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study.
Dig Dis Sci
; 67(9): 4525-4532, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35246801
13.
A Scoring System to Determine Patients' Risk of Colectomy Within 1 Year After Hospital Admission for Acute Severe Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 19(8): 1602-1610.e1, 2021 08.
Article
in English
| MEDLINE | ID: mdl-31927106
14.
Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study.
Gut
; 69(5): 852-858, 2020 05.
Article
in English
| MEDLINE | ID: mdl-31446428
15.
Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 18(6): 1324-1335.e2, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32059920
16.
Nancy Index Scores of Chronic Inflammatory Bowel Disease Activity Associate With Development of Colorectal Neoplasia.
Clin Gastroenterol Hepatol
; 18(1): 150-157.e1, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31085339
17.
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID.
Am J Gastroenterol
; 115(11): 1812-1820, 2020 11.
Article
in English
| MEDLINE | ID: mdl-33156100
18.
Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
Eur J Clin Pharmacol
; 76(3): 449-457, 2020 Mar.
Article
in English
| MEDLINE | ID: mdl-31838548
19.
Balancing Benefit vs Risk of Immunosuppressive Therapy for Individual Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 17(3): 370-379, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30031174
20.
Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.
Gastroenterology
; 155(2): 337-346.e10, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29655835